8-(4-((2-aminoethyl)aminocarbonylmethyloxy)phenyl)-1,3-dipropylxanthine has been researched along with Lupus Erythematosus, Systemic in 1 studies
8-(4-((2-aminoethyl)aminocarbonylmethyloxy)phenyl)-1,3-dipropylxanthine: adenosine receptor antagonist
Lupus Erythematosus, Systemic: A chronic, relapsing, inflammatory, and often febrile multisystemic disorder of connective tissue, characterized principally by involvement of the skin, joints, kidneys, and serosal membranes. It is of unknown etiology, but is thought to represent a failure of the regulatory mechanisms of the autoimmune system. The disease is marked by a wide range of system dysfunctions, an elevated erythrocyte sedimentation rate, and the formation of LE cells in the blood or bone marrow.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Loza, MJ | 1 |
| Anderson, AS | 1 |
| O'Rourke, KS | 1 |
| Wood, J | 1 |
| Khan, IU | 1 |
1 other study available for 8-(4-((2-aminoethyl)aminocarbonylmethyloxy)phenyl)-1,3-dipropylxanthine and Lupus Erythematosus, Systemic
| Article | Year |
|---|---|
T-cell specific defect in expression of the NTPDase CD39 as a biomarker for lupus.
Topics: Adenosine; Adult; Aged; Antigens, CD; Apyrase; Biomarkers; Cell Proliferation; Cells, Cultured; Flow | 2011 |